Back
Allogene Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
4
ALLO
Allogene Therapeutics
Last Price:
$1.88
Seasonality Move:
0.51%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALLO is experiencing slight buying pressure.
Allogene Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.97 | Sell |
| 20-day SMA: | 2.18 | Sell |
| 50-day SMA: | 2.48 | Sell |
| 200-day SMA: | 2.86 | Sell |
| 8-day EMA: | 1.98 | Sell |
| 20-day EMA: | 2.14 | Sell |
| 50-day EMA: | 2.37 | Sell |
| 200-day EMA: | 2.88 | Sell |
Allogene Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 36.26 | Sell |
| Chaikin Money Flow: | 998415 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.98 - 2.38) | Sell |
| Bollinger Bands (100): | (2.26 - 2.86) | Sell |
Allogene Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Allogene Therapeutics Stock
Is Allogene Therapeutics Stock a Buy?
-
Allogene Therapeutics share price is 1.87 while ALLO 8-day simple moving average is 1.97, which is a Sell signal.
-
The stock price of ALLO is 1.87 while Allogene Therapeutics 20-day SMA is 2.18, which makes it a Sell.
-
Allogene Therapeutics 50-day simple moving average is 2.48 while ALLO share price is 1.87, making it a Sell technically.
-
ALLO stock price is 1.87 and Allogene Therapeutics 200-day simple moving average is 2.86, creating a Sell signal.
ALLO Technical Analysis vs Fundamental Analysis
Sell
4
Allogene Therapeutics (ALLO)
is a Sell
Is Allogene Therapeutics a Buy or a Sell?
-
Allogene Therapeutics stock is rated a SellThe current Allogene Therapeutics [ALLO] share price is $1.87. The Score for ALLO is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
Allogene Therapeutics Stock Info
Market Cap:
392.1M
Price in USD:
1.87
Share Volume:
5M
Allogene Therapeutics 52-Week Range
52-Week High:
5.78
52-Week Low:
1.78
Sell
4
Allogene Therapeutics (ALLO)
is a Sell
Allogene Therapeutics Share Price Forecast
-
What is the Allogene Therapeutics stock price today?The Allogene Therapeutics stock price is 1.87 USD today.
-
Will ALLO stock go up or go down?Allogene Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Allogene Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Allogene Therapeutics is overvalued.
Is Allogene Therapeutics Stock a Buy?
-
Allogene Therapeutics share price is 1.87 while ALLO 8-day exponential moving average is 1.98, which is a Sell signal.
-
The stock price of ALLO is 1.87 while Allogene Therapeutics 20-day EMA is 2.14, which makes it a Sell.
-
Allogene Therapeutics 50-day exponential moving average is 2.37 while ALLO share price is 1.87, making it a Sell technically.
-
ALLO stock price is 1.87 and Allogene Therapeutics 200-day simple moving average is 2.88, creating a Sell signal.
Fundamental Analysis of Allogene Therapeutics
Is Allogene Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.07 per share.
Technical Analysis of Allogene Therapeutics
Should I short Allogene Therapeutics stock?
-
ALLO Moving Average Covergence Divergence (MACD) indicator is -0.17, suggesting Allogene Therapeutics is a Sell
-
Allogene Therapeutics Relative Strength Index (RSI) is 36.26, which suggest Allogene Therapeutics is oversold
-
The Bollinger Bands (25) for Allogene Therapeutics is (1.98 - 2.38), which suggest Allogene Therapeutics is a Sell
-
The Bollinger Bands (100) for Allogene Therapeutics is (2.26 - 2.86), which suggest Allogene Therapeutics is a Sell
* Allogene Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.